Trends in the management and burden of alcoholic liver disease

Journal of Hepatology

Volumn 62, Issue S1, 2015, Pages S38-S46

  Mathurin, Philippe ^a   Bataller, Ramon ^b  

^a UNIVERSITÉ DE LILLE   (France)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholic hepatitis; Burden of alcoholic liver disease; Cirrhosis; Liver transplantation; Natural history; Non invasive diagnosis

Indexed keywords

ALCOHOL; CORTICOSTEROID;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; FATTY LIVER; HEALTH CARE POLICY; HEREDITY; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; RISK FACTOR; SEVERE HEPATIC IMPAIRMENT; SHORT TERM SURVIVAL; TREATMENT DURATION; TREND STUDY; COST OF ILLNESS; HEPATITIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC;

COST OF ILLNESS; HEPATITIS, ALCOHOLIC; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION;

EID: 84945304661     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.03.006     Document Type: Review

References (113)

1. J. Rehm, R. Room, M. Monteiro, and et al. Alcohol as a risk factor for global burden of disease Eur Addict Res 9 2003 157 164
2. European Association for the Study of Liver EASL clinical practical guidelines: management of alcoholic liver disease J Hepatol 57 2012 399 420
3. G. Askgaard, M. Gronbaek, M.S. Kjaer, and et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study J Hepatol 2015 10.1016/j.jhep.2014.12.005 in press
4. S. Zakhari, and T. Li Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease Hepatology 46 2007 2032 2039
5. S. Pincock Binge drinking on rise in UK and elsewhere Lancet 362 2003 1126 1127
6. T.S. Naimi, R. Brewer, A. Mokdad, C. Denny, M.K. Serdula, and J.S. Marks Binge drinking among US adult JAMA 289 2003 70 75
7. J. McAlaney, and J. McMahon Establishing rates of binge drinking in the UK: anomalies in the data Alcohol Alcohol 41 2006 355 357
8. P. Mathurin, and P. Delterne Effect of binge drinking on the liver: an alarming public health issue? Gut 58 2009 613 617
9. R. Hingson, T. Heeren, M. Winter, and H. Wechsler Magnitude of alcohol-related mortality and morbidity among U.S. college students ages 18-24: changes from 1998 to 2001 Annu Rev Public Health 26 2005 259 279
10. D.A. Leon, and J. McCambridge Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data Lancet 367 2006 52 56
11. J.W. Miller, T. Naimi, R.D. Brewer, and S.E. Jones Binge drinking and associated health risk behaviors among high school students Pediatrics 119 2007 76 85
12. G. Corrao, V. Bagnardi, A. Zambon, and P. Torchio Meta-analysis of alcohol intake in relation to risk of liver cirrhosis Alcohol Alcohol 33 1998 381 392
13. S. Bellentani, G. Saccoccio, G. Costa, C. Tiribelli, F. Manenti, M. Sodde, and et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group Gut 41 1997 845 850
14. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, and et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
15. C.J.L. Murray, T. Vos, R. Lozano, M. Naghavi, A.D. Flaxman, C. Michaud, and et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2197 2223
16. J. Rehm, A. Samokhvalov, and K.D. Shield Global burden of alcoholic liver diseases J Hepatol 2013 160 168
17. J. Jewell, and N. Sheron Trends in European liver death rates: implications for alcohol policy Clin Med 10 2010 259 263
18. C. Bosetti, F. Levi, F. Lucchini, W.A. Zatonski, E. Negri, and C. La Vecchia Worldwide mortality from cirrhosis: an update to 2002 J Hepatol 46 2007 827 839
19. D.A. Leon, V. Shkolnikov, and M. McKee Alcohol and Russian mortality: a continuing crisis Addiction 104 2009 1630 1636
20. G. Corrao, P. Ferrari, A. Zambon, P. Torchio, S. Arico, and A. Decarli Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption Int J Epidemiol 26 1997 100 109
21. C. La Vecchia Alcohol in the Mediterranean diet: benefits and risks Int J Vitam Nutr Res 71 2001 210 213
22. M. Ramstedt Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries Addiction 96 2001 S19 S33
23. R. Adam, P. McMaster, J.G. O'Grady, and et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry Liver Transpl 9 2003 1231 1243
24. A.C. Wagenaar, A.L. Tobler, and K.A. Komro Effects of alcohol tax and price policies on morbidity and mortality: a systematic review Am J Public Health 100 2010 2270 2278
25. A.C. Wagenaar, M.J. Salois, and K.A. Komro Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies Addiction 104 2009 179 190
26. A. Brennan, Y. Meng, J. Holmes, and et al. Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study BMJ 349 2014 g5452
27. M.R.D.C. Teli, A.D. Burt, M.K. Bennett, and O.F. James Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
28. J.H. Lefkowitch Morphology of alcoholic liver disease Clin Liver Dis 9 2005 37 53
29. M. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
30. M. Adachi, and D. Brenner Clinical syndromes of alcoholic liver disease Dig Dis Sci 23 2005 255 263
31. B. Gao, and R. Bataller Alcoholic liver disease: pathogenesis and new therapeutic targets Gastroenterology 141 2011 1572 1585
32. H. Tsukamoto, S. Cheng, and W.S. Blanner Effects of dietary polyunsaturated fat on ethanol-induced Ito cell activation Am J Physiol 270 1996 G581 G586
33. H. Tsukamoto, W. Horne, S. Kamimura, O. Niemelä, S. Parkkila, S. Ylä-Herttuala, and et al. Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 96 1995 620 630
34. H. Tsukamoto, Y. Takei, C.J. McClain, S. Joshi-Barve, D. Hill, J. Schmidt, and et al. How is the liver primed or sensitized for alcoholic liver disease? Alcohol Clin Exp Res 25 2001 171S 181S
35. G.E. Vaillant A 60-year follow-up of alcoholic men Addiction 98 2003 1043 1051
36. A. DiMartini, M.A. Dew, N. Day, and et al. Trajectories of alcohol consumption following liver transplantation Am J Transplant 10 2010 2305 2312
37. Z. Hrubec, and G. Omenn Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans Alcohol Clin Exp Res 5 1981 207 215
38. F. Stickel, S. Buch, K. Lau, H. Meyer zu Schwabedissen, T. Berg, M. Ridinger, and et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians Hepatology 53 2010 86 95
39. E. Trépo, T. Gustot, D. Degré, A. Lemmers, L. Verset, P. Demetter, and et al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease J Hepatol 55 2011 906 912
40. C. Tian, R. Stokowski, D. Kershenobich, D.G. Ballinger, and D.A. Hinds Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease Nat Genet 42 2010 21 23
41. Y.L. Liu, G.L. Patman, J.B. Leathart, and et al. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma J Hepatol 61 2014 75 81
42. R. Bataller, and K. North Brenner DA Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503
43. S. Naveau, V. Giraud, E. Borotto, A. Aubert, F. Capron, and J.C. Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111
44. T. Poynard, P. Mathurin, C.L. Lai, D. Guyader, R. Poupon, M.H. Tainturier, and et al. A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 2003 257 265
45. P. Mathurin, F. Beuzin, A. Louvet, N. Carrie-Ganne, A. Balian, J.C. Trinchet, and et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features Aliment Pharmacol Ther 25 2007 1047 1054
46. S. Dam-Larsen, M. Franzmann, I.B. Andersen, P. Christoffersen, L.B. Jensen, T.I. Sørensen, and et al. Long term prognosis of fatty liver: risk of chronic liver disease and death Gut 53 2004 750 755
47. J. Altamirano, R. Miquel, A. Katoonizadeh, J.G. Abraldes, A. Duarte-Rojo, A. Louvet, and et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis Gastroenterology 146 2014 1231 1239
48. B. Raynard, A. Balian, D. Fallik, F. Capron, P. Bedossa, J.C. Chaput, and et al. Risk factors of fibrosis in alcohol-induced liver disease Hepatology 35 2002 635 638
49. W. Dunn, A.J. Sanyal, E.M. Brunt, and et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD) J Hepatol 57 2012 384 391
50. B. Hock, M. Schwarz, I. Domke, and et al. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin Addiction 100 2005 1477 1486
51. P. Alatalo, H. Koivisto, K. Puukka, and et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers Alcohol Alcohol 44 2009 199 203
52. R.N. MacSween, and A.D. Burt Histologic spectrum of alcoholic liver disease Semin Liver Dis 6 1986 221 232
53. L. Chrostek, and A. Panasiuk Liver fibrosis markers in alcoholic liver disease World J Gastroenterol 20 2014 8018 8023
54. S. Naveau, G. Gaudé, A. Asnacios, H. Agostini, A. Abella, N. Barri-Ova, and et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease Hepatology 49 2009 97 105
55. L. Castera, and M. Pinzani Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59 2010 861 866
56. P. Nahon, A. Kettaneh, J. Tengher-Barna, M. Ziol, V. de Lédinghen, C. Douvin, and et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease J Hepatol 49 2008 1062 1068
57. E. Nguyen-Khac, P. Saint-Leger, B. Tramier, H. Coevoet, D. Capron, and J.L. Dupas Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology Alcohol Clin Exp Res 34 2010 1146 1153
58. S. Mueller, G. Millonig, L. Sarovska, and et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis World J Gastroenterol 16 2010 966 972
59. E. Gelsi, R. Dainese, R. Truchi, and et al. Effect of detoxification on liver stiffness assessed by Fibroscan(R) in alcoholic patients Alcohol Clin Exp Res 35 2011 566 570
60. S.M. Penny Alcoholic liver disease Radiol Technol 84 2013 577 592 quiz 593-595
61. G. d'Assignies, G. Fontes, C. Kauffmann, and et al. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels Metabolism 62 2013 1850 1857
62. H.P. Porter, F.R. Simon, C.E. Pope II, and et al. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial N Engl J Med 284 1971 1350 1355
63. J.A. Cohen, and M. Kaplan The SGOT/SGPT ratio - An indicator of alcoholic liver disease Dig Dis Sci 24 1979 835 838
64. J. Altamirano, C. Fagundes, M. Dominguez, E. Garcia, J. Michelena, A. Cardenas, and et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis Clin Gastroenterol Hepatol 10 2012 e3
65. P. Kryger, P. Schlichting, O. Dietrichson, and E. Juhl The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis Scand J Gastroenterol 18 1983 691 696
66. R.P. Mookerjee, C. Lackner, R. Stauber, V. Stadlbauer, M. Deheragoda, A. Aigelsreiter, and et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis J Hepatol 55 2011 1103 1111
67. T. Hardy, C. Wells, S. Kendrick, M. Hudson, C.P. Day, A.D. Burt, and et al. White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers BMC Gastroenterol 2013 2013 55 59
68. P. Mathurin, and M. Lucey Management of alcoholic hepatitis J Hepatol 56 2012 S39 S45
69. J. Altamirano, C. Fagundes, M. Dominguez, and et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis Clin Gastroenterol Hepatol 10 2012 e3
70. T.D. Sandahl, P. Jepsen, K.L. Thomsen, and H. Vilstrup Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study J Hepatol 54 2011 760 764
71. S. Liangpunsakul Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States J Clin Gastroenterol 45 2011 714 719
72. M. Dominguez, D. Rincon, J.G. Abraldes, R. Miquel, J. Colmenero, P. Bellot, and et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis Am J Gastroenterol 103 2008 2747 2756
73. W. Dunn, L. Jamil, L.S. Brown, R.H. Wiesner, W.R. Kim, K.V.N. Menon, and et al. MELD accurately predicts mortality in patients with alcoholic hepatitis Hepatology 41 2005 353 358
74. E.H. Forrest, C. Evans, S. Stewart, M. Phillips, Y.H. Oo, N.C. McAvoy, and et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score Gut 54 2005 1174 1179
75. R.L. Carithers Jr., H. Herlong, A.M. Diehl, E.W. Shaw, B. Combes, H.J. Fallon, and et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial Ann Intern Med 110 1989 685 690
76. A. Louvet, S. Naveau, M. Abdelnour, M.J. Ramond, E. Diaz, L. Fartoux, and et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
77. A. Louvet, E. Diaz, S. Dharancy, H. Coevoet, F. Texier, T. Thévenot, and et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids J Hepatol 48 2008 465 470
78. A. Louvet, F. Wartel, H. Castel, S. Dharancy, A. Hollebecque, V. Canva-Delcambre, and et al. Prospective screening of infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor Gastroenterology 137 2009 541 548
79. A.K. Singal, and M.R. Charlton Nutrition in alcoholic liver disease Clin Liver Dis 16 2012 805 826
80. R.F. Butterworth Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease Metab Brain Dis 10 1995 1 8
81. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
82. EASL EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
83. R.S. O'Shea, S. Dasarathy, and A.J. McCullough Alcoholic liver disease Am J Gastroenterol 105 2010 14 32
84. S.H. Park, D.J. Kim, Y.S. Kim, H.J. Yim, W.Y. Tak, H.J. Lee, and et al. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial J Hepatol 61 2014 792 798
85. M. Thursz, P. Richardson, M.E. Allison, A. Austin, M. Bowers, C.P. Day, and et al. Steroids or pentoxifylline for alcoholic hepatitis: results of the STOPAH trial Hepatology 60 2014 LB1
86. T.F. Imperiale, and A. McCullough Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 113 1990 299 307
87. W.C. Maddrey, J. Boitnott, M.S. Bedine, F.L. Weber, E. Mezey, and R.I. White Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193 199
88. P. Mathurin, C. Mendenhall, R.L. Carithers Jr., M.J. Ramond, W.C. Maddrey, P. Garstide, and et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials J Hepatol 36 2002 480 487
89. C.L. Mendenhall, S. Anderson, P. Garcia-Pont, S. Goldberg, T. Kiernan, L.B. Seef, and et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone N Engl J Med 311 1984 1464 1470
90. M.J. Ramond, T. Poynard, B. Rueff, P. Mathurin, C. Theodore, J.C. Chaput, and et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis N Engl J Med 326 1992 507 512
91. P. Mathurin, J. O'Grady, R.L. Carithers, M. Phillips, A. Louvet, C.L. Mendenhall, and et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data Gut 60 2011 255 260
92. T. Gustot, E. Maillart, M. Bocci, and et al. Invasive aspergillosis in patients with severe alcoholic hepatitis J Hepatol 60 2014 267 274
93. P. Mathurin, A. Louvet, A. Duhamel, P. Nahon, N. Carbonell, J. Boursier, and et al. Prednisolone with vs. Without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial JAMA 310 2013 1033 1041
94. E. Nguyen-Khac, T. Thevenot, M.A. Piquet, S. Benferhat, O. Goria, D. Chatelain, and et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis N Engl J Med 365 2011 1781 1789
95. V. Donckier, V. Lucidi, T. Gustot, and C. Moreno Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy J Hepatol 60 2014 866 871
96. P. Mathurin, C. Moreno, D. Samuel, J. Dumortier, J. Salleron, F. Durand, and et al. Early liver transplantation for severe alcoholic hepatitis N Engl J Med 365 2011 1790 1800
97. M.J. Englesbe, S.P. Patel, K. He, and et al. Sarcopenia and mortality after liver transplantation J Am Coll Surg 211 2010 271 278
98. T.P. Beresford, and G.T. Everson Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse - but where are the data? Liver Transpl 6 2000 777 778
99. Consensus conference: indications for liver transplantation, January 19 and 20, Lyon-Palais Des Congrès: text of recommendations (long version) Liver Transpl 2006 2005 998 1011
100. R.M. Merion, D.E. Schaubel, D.L. Dykstra, R.B. Freeman, F.K. Port, and R.A. Wolfe The survival benefit of liver transplantation Am J Transplant 5 2005 307 313
101. M.R. Lucey Liver transplantation for alcoholic liver disease: past, present, and future Liver Transpl 13 2007 190 192
102. M.R. Lucey How will patients be selected for transplantation in the future? Liver Transpl 10 2004 S90 S92
103. P. Burra, and M.R. Lucey Liver transplantation in alcoholic patients Transpl Int 1 2005 491 498
104. P. Burra, D. Mioni, U. Cillo, S. Fagiuoli, M. Senzolo, R. Naccarato, and et al. Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease Transpl Int 13 2000 S174 S178
105. D.M. Bravata, I. Olkin, A.E. Barnato, E.B. Keeffe, and D.K. Owens Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review Liver Transpl 7 2001 191 203
106. A. DiMartini, N. Day, M.A. Dew, L. Javed, M.G. Fitzgerald, A. Jain, and et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease Liver Transpl 12 2006 813 820
107. G. Pageaux, M. Bismuth, P. Perney, V. Costes, S. Jaber, P. Possoz, and et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 38 2003 629 634
108. R. Pfitzmann, J. Schwenzer, N. Rayes, D. Seehofer, R. Neuhaus, and N.C. Nussler Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease Liver Transpl 13 2007 197 205
109. P. Burra, M. Senzolo, R. Adam, and et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry) Am J Transplant 10 2010 138 148
110. C.S. Ahn, S. Hwang, K.H. Kim, and et al. Long-term outcome of living donor liver transplantation for patients with alcoholic liver disease Transplant Proc 46 2014 761 766
111. P.J. Gaglio Jr., and P.J. Gaglio Sr. Complications in patients with alcohol-associated liver disease who undergo liver transplantation Clin Liver Dis 16 2012 865 875
112. J.I. Herrero, F. Pardo, D. D'Avola, and et al. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal Liver Transpl 17 2011 402 408
113. C. Jimenez-Romero, A. Manrique, E. Marques, and et al. Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience Hepatogastroenterology 58 2011 115 121